Enginprime Medical raises $12M
Enginprime Medical announced a Series A round of $12M on 18 August 2026. The company operates in HealthTech and is based in China. It was founded by Zhiyong Liu, CEO. Announced 45 days ago.
Founder
Zhiyong Liu
CEO, Enginprime Medical
Outreach angles
- -Enginprime Medical was founded in 2023 by Voyagers Capital as a dedicated venture to build next-generation ventricular assist devices.
- -CEO Zhiyong Liu is steering the company's flagship OpusOne device through China's national regulatory trial process.
- -The Series A funding from Qiming Venture Partners will move OpusOne into registration clinical trials in China ahead of global submissions.
Signals
Series AHealthcareDeep TechHardwareRegulated Industry
Round details
Company: Enginprime Medical
Domain: enginprime.com
Amount: $12M
Stage: Series A
Industry: HealthTech
Country: China
Announced: 18 August 2026
Other HealthTech raises
Recently funded in China